(Press-News.org) CHAMPAIGN, Ill. — An ancient biological enzyme known as nickel-iron hydrogenase may play a key role in producing hydrogen for a renewables-based energy economy, researchers said. Careful study of the enzyme has led chemists from the University of Illinois Urbana-Champaign to design a synthetic molecule that mimics the hydrogen gas-producing chemical reaction performed by the enzyme.
The researchers reported their findings in the journal Nature Communications.
Currently, industrial hydrogen is usually produced by separating hydrogen gas molecules from oxygen atoms in water using a process called electrolysis. To boost this chemical reaction in the industrial setting, platinum metal is used as a catalyst in the cathodes that direct the reaction. However, many studies have shown that the expense and rarity of platinum make it unattractive as the world pushes toward more environmentally sound energy sources.
On the other hand, nature's nickel-iron hydrogenase enzyme produces hydrogen using earth-abundant metals in its core, said chemistry professor Liviu Mirica, who led the study with graduate student Sagnik Chakrabarti.
“The nickel at the core of the natural enzyme produces hydrogen by reducing protons in water,” Chakrabarti said. “During the catalytic process, the nickel center goes through paramagnetic intermediates, meaning that the intermediates have an unpaired electron – which makes them extremely short-lived.”
Synthetic chemists have made nickel compounds that produce hydrogen for over a decade, Mirica said. While some of these compounds are very efficient at producing hydrogen, the vast majority of them operate via intermediates that are not paramagnetic.
“Researchers are trying to mimic exactly what nature does because it is efficient, and maximizing efficiency is a key challenge to overcome when engineering energy sources,” Mirica said. “Being able to reproduce the paramagnetic intermediate steps that occur in the natural enzyme is what our group is trying to achieve – to increase efficiency and mimic nature.”
To achieve this, the team designed an organic molecule called a ligand that contains electron-donating atoms like nitrogen and sulfur, and can hold the nickel in place and support the two relevant paramagnetic states that produce hydrogen. The key design element that sets this molecule apart from other catalysts is the presence of a carbon-hydrogen bond near the nickel center that is broken and re-formed during catalysis. This was crucial in stabilizing the aforementioned paramagnetic states.
“One of the key takeaways from our work is that by using the specially designed ligand in the manner we did, we have successfully united ideas from two fields of inorganic chemistry – bioinorganic and organometallic chemistry – to make nickel complexes that behave similarly to the active site of one of nature’s most beautiful and complicated enzymes,” Chakrabarti said.
In the recent past, several unusual enzymes have been found that feature metal-carbon bonds in their active sites, the researchers said. Such design principles in synthetic complexes could lead to further insights into how nature performs chemistry with small molecules like hydrogen.
Former Illinois researchers Soumalya Sinha, Giang N. Tran and Hanah Na contributed to this study. The National Science Foundation supported this research.
Mirica also is affiliated with the neuroscience program, the Beckman Institute for Advanced Science and Technology and the Carle Illinois College of Medicine at Illinois.
Editor’s notes:
To reach Liviu Mirica, email mirica@illinois.edu.
The paper “Characterization of paramagnetic states in an organometallic nickel hydrogen evolution electrocatalyst” is available online.
DOI: 10.1038/s41467-023-36609-7.
END
Mimicking biological enzymes may be key to hydrogen fuel production
2023-03-29
ELSE PRESS RELEASES FROM THIS DATE:
Ochsner Health named 2023 Gallup Exceptional Workplace Award Winner
2023-03-29
NEW ORLEANS, LOUISIANA— Ochsner Health, Louisiana’s largest nonprofit, academic, multi-specialty, healthcare delivery system, has received the 2023 Gallup Exceptional Workplace Award (GEWA). This award recognizes the most engaged workplace cultures in the world.
After another year of unpredictability in the workplace, Gallup found that Ochsner Health continued to put their employees’ engagement at the center of their business strategy, embedding engagement into their very culture.
“Our employees are the reason for the culture of positive engagement at Ochsner Health. From physicians and providers to clinical ...
Heart attack study could change the game in regenerative medicine
2023-03-29
LA JOLLA, CALIF. Mar 29, 2023 - Sanford Burnham Prebys researchers have identified a group of proteins that could be the secret to cellular reprogramming, an emerging approach in regenerative medicine in which scientists transform cells to repair damaged or injured body tissues. The researchers were able to reprogram damaged heart cells to repair heart injuries in mice following a heart attack. The findings, which appear in the journal Nature Communications, could one day transform the way we treat a variety of diseases, including cardiovascular disease, Parkinson’s ...
Do your headaches happen at the same time of day?
2023-03-29
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, MARCH 29, 2023
MINNEAPOLIS – Both cluster headache and migraine have strong links to the circadian system, the internal clock that regulates body processes, according to a meta-analysis published in the March 29, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The meta-analysis included all available studies on cluster headache and migraine that included circadian features. This included information on the timing of headaches during ...
Imaging brain connections can predict improvements in obsessive-compulsive disorder patients after deep brain stimulation
2023-03-29
Deep brain stimulation (DBS) is a promising therapy for treatment-resistant obsessive-compulsive disorder (OCD). A first-of-its-kind collaborative study led by researchers at Texas Children’s Hospital, Baylor College of Medicine, and Brigham & Women’s Hospital has found that mapping neural connections in the brains of OCD patients offers key insights that explain the observed improvements in their clinical outcomes after DBS. The study was published in Biological Psychiatry.
Neuropsychiatric disorders such as obsessive-compulsive ...
Lab-made antibodies offer potential cure for yellow fever
2023-03-29
PORTLAND, Oregon -- New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.
The natural immune response to invading pathogens normally involves making protective proteins called antibodies. A study published today in Science Translational Medicine suggests that a single monoclonal antibody infusion can strengthen the body’s fight against yellow fever.
In the study, the yellow fever virus was undetectable in all animals that received monoclonal antibody infusions after being exposed to the virus.
“Two ...
Evermed, ACC launch ACC Anywhere, the 'Netflix of Cardiology'
2023-03-29
Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new content hub that provides cardiologists around the world with on-demand access to the latest clinical knowledge. The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future.
Evermed was selected to collaborate with ACC due to its advanced AI-powered recommender engine and its ability to effectively deliver medical education content 365 days per year. In addition, Evermed’s technology will help drive yearlong engagement to ensure that users are able ...
The clinical presentation of IDDMSSD syndrome is likely associated with the molecular location of the mutation in the PAK1 gene
2023-03-29
A recent study from Texas Children’s Hospital and Baylor College of Medicine has expanded the clinical spectrum of a new epileptic disorder called Intellectual Developmental Disorder with Macrocephaly, Seizures, and Speech Delay (IDDMSSD) with the identification of the first recurrently affected residue identified in the protein kinase domain of PAK1 protein. The study, published in the American Journal of Medical Genetics: Part A, found potential correlations between how and which organ ...
Downregulation of angulin-1/LSR induces malignancy in lung adenocarcinoma
2023-03-29
“In the present study, we found that downregulation of angulin-1/LSR induced malignancy via upregulation of EGF-dependent CLDN-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma.”
BUFFALO, NY- March 29, 2023 – A new research paper was published in Oncotarget's Volume 14 on March 24, 2023, entitled, “Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells.”
Abnormal expression of bicellular tight junction claudins, including ...
Bridging the Gap: addressing medical and social needs improves diabetes care and outcomes
2023-03-29
Nearly one in five American adults has diabetes. But that doesn’t mean the common condition is simple to treat or manage. Diabetes and its complications are the No. 1 cause of kidney failure, adult blindness, and lower-limb amputations. It’s also the seventh-leading cause of death in the U.S. As with so many chronic conditions, diabetes also disproportionately affects the most vulnerable in our communities, further exacerbating existing health disparities.
In a new supplemental issue of the ...
Research Brief: Study finds evidence of resistance to COVID-19 drugs
2023-03-29
(03/29/2023) — Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug known as a protease inhibitor could soon become less effective in treating COVID-19 infections.
This conclusion was presented in a study published today online in the peer-reviewed journal Science Advances.
This study — conducted by the Midwest Antiviral Drug Discovery (AViDD) Center — shows that drug-resistant variants have appeared multiple times independently in different parts of the world, with regional clusters providing evidence for person-to-person transmission. In ...